Status:

COMPLETED

Attitudes About Childbearing And Fertility With Inherited Breast And Ovarian Cancer Syndromes (HBOC)

Lead Sponsor:

M.D. Anderson Cancer Center

Conditions:

Breast Cancer

Ovarian Cancer

Eligibility:

FEMALE

18+ years

Brief Summary

Objectives: \- To evaluate the attitudes and opinions of women undergoing genetic counseling for hereditary breast and ovarian cancer syndrome, both before and after testing, in regards to pregnancy ...

Detailed Description

This questionnaire is part of a study at The University of Texas M.D. Anderson Cancer Center. The purpose is to ask women who are seeking genetic testing for HBOC their viewpoints surrounding fertilit...

Eligibility Criteria

Inclusion

  • Women who have been referred to the Clinical Cancer Genetics Program for discussion of Hereditary Breast And Ovarian Syndrome (HBOC).
  • Participants must be seen by clinical cancer geneticist and undergo genetic counseling here at M.D. Anderson Cancer Center for HBOC.
  • Participants may or may not have a personal diagnosis of cancer.
  • Participants may have already seen or undergone reproductive endocrine evaluation and had any reproductive treatment.
  • The participant must be a woman and have reproductive potential which would include either active menstruation, blood tests with premenopausal ranges of Luteinizing Hormone (LH), Follicle Stimulating Hormone (FSH) and estradiol, or was premenopausal prior to starting chemotherapy for a diagnosed breast cancer.
  • Age \>/= 18 years old
  • The patient must be able to speak and read fluently in either English or in Spanish in order to complete the questionnaire.

Exclusion

  • 1\) None

Key Trial Info

Start Date :

February 1 2009

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 1 2016

Estimated Enrollment :

156 Patients enrolled

Trial Details

Trial ID

NCT00829959

Start Date

February 1 2009

End Date

August 1 2016

Last Update

August 4 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Texas MD Anderson Cancer Center

Houston, Texas, United States, 77030